Medtronic Announces Scientific Data Presentations at the American Diabetes Association 80th Scientific Sessions

Medtronic to Release New Data on Advanced Hybrid Closed-Loop Systems and Extended-Wear Infusion SetDUBLIN, June 09, 2020 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its participation at the American Diabetes Association 80th scientific sessions virtual meeting, June 12-16, 2020. Medtronic will be participating in this year’s ADA virtual sessions with 16 data presentations, a symposium, a product theater, and a virtual exhibit. Though its diverse ADA offerings, Medtronic will showcase the company’s automated insulin pump systems, continuous glucose monitoring (CGM) systems, and extended-wear infusion set technology; meaningful outcomes and differentiated support offerings, such as telehealth capabilities and the company response to the COVID-19 pandemic.
Bay Street News

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search